132 related articles for article (PubMed ID: 37334716)
21. Characteristics and predictors of ICU-mortality in critically ill patients with hyperlactatemia requiring CRRT: A retrospective cohort study.
Li L; Bai M; Zhang Q; Sun S
Int J Artif Organs; 2022 Dec; 45(12):973-980. PubMed ID: 36151706
[TBL] [Abstract][Full Text] [Related]
22. Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease.
Chan SY; Ou SM; Chen YT; Shih CJ
Int J Cardiol; 2016 Sep; 218():170-175. PubMed ID: 27236110
[TBL] [Abstract][Full Text] [Related]
23. Diffuse idiopathic skeletal hyperostosis is associated with incident stroke in patients with increased cardiovascular risk.
Harlianto NI; Oosterhof N; Foppen W; Hol ME; Wittenberg R; van der Veen PH; van Ginneken B; Mohamed Hoesein FAA; Verlaan JJ; de Jong PA; Westerink J;
Rheumatology (Oxford); 2022 Jul; 61(7):2867-2874. PubMed ID: 34791065
[TBL] [Abstract][Full Text] [Related]
24. Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study.
Wu MH; Tsou PY; Wang YH; Lee MG; Chao CCT; Lee WC; Lee SH; Hu JR; Wu JY; Chang SS; Lee CC
Crit Care; 2019 Sep; 23(1):293. PubMed ID: 31477181
[TBL] [Abstract][Full Text] [Related]
25. Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease.
Ou SM; Lee KH; Tsai MT; Tseng WC; Chu YC; Tarng DC
Front Med (Lausanne); 2022; 9():809292. PubMed ID: 35280875
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level.
Gue YX; Bisson A; Bodin A; Herbert J; Lip GYH; Fauchier L
Eur J Clin Invest; 2022 Jun; 52(6):e13754. PubMed ID: 35113450
[TBL] [Abstract][Full Text] [Related]
27. The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure.
Lin DS; Lin FJ; Lin YS; Lee JK; Lin YH
Eur J Heart Fail; 2023 Jan; 25(1):98-107. PubMed ID: 36404402
[TBL] [Abstract][Full Text] [Related]
28. Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury.
Kim SG; Lee J; Yun D; Kang MW; Kim YC; Kim DK; Oh KH; Joo KW; Kim YS; Han SS
BMC Nephrol; 2023 Jan; 24(1):11. PubMed ID: 36641421
[TBL] [Abstract][Full Text] [Related]
29. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
[TBL] [Abstract][Full Text] [Related]
30. Association between hyperlactatemia and occult cardiac failure in diabetic patients on maintenance hemodialysis.
Varol U; Varol Y; Yaprak M; Uzum A; Cirit M
Int Urol Nephrol; 2014 Aug; 46(8):1639-44. PubMed ID: 24356918
[TBL] [Abstract][Full Text] [Related]
31. Hyperlactatemia and the Outcome of Type 2 Diabetic Patients Suffering Acute Myocardial Infarction.
Aleksandar J; Vladan P; Markovic-Jovanovic S; Stolic R; Mitic J; Smilic T
J Diabetes Res; 2016; 2016():6901345. PubMed ID: 27975067
[No Abstract] [Full Text] [Related]
32. Prognostic performance of GRACE and TIMI risk scores in critically ill patients with sepsis and a concomitant myocardial infarction.
Desnos C; Ederhy S; Belnou P; Lapidus N; Lefevre G; Voiriot G; Cohen A; Fartoukh M; Labbé V
Arch Cardiovasc Dis; 2022; 115(6-7):359-368. PubMed ID: 35710774
[TBL] [Abstract][Full Text] [Related]
33. Frequency of Hyperlactatemia in Intensive Care Patients within Tertiary Care Hospital in Pakistan.
Sheikh T; Shuja H; Bin Waqar SH
Cureus; 2020 May; 12(5):e8264. PubMed ID: 32596081
[TBL] [Abstract][Full Text] [Related]
34. Long-term cardiovascular outcomes after orlistat therapy in patients with obesity: a nationwide, propensity-score matched cohort study.
Ardissino M; Vincent M; Hines O; Amin R; Eichhorn C; Tang AR; Collins P; Moussa O; Purkayastha S
Eur Heart J Cardiovasc Pharmacother; 2022 Feb; 8(2):179-186. PubMed ID: 33991094
[TBL] [Abstract][Full Text] [Related]
35. Dose-response effects of physical activity on all-cause mortality and major cardiorenal outcomes in chronic kidney disease.
Kuo CP; Tsai MT; Lee KH; Lin YP; Huang SS; Huang CC; Tseng WC; Tarng DC
Eur J Prev Cardiol; 2022 Mar; 29(3):452-461. PubMed ID: 33704426
[TBL] [Abstract][Full Text] [Related]
36. Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure.
Woo JS; Hwang SJ; Kim HS; Kim JB; Kim WS; Kim KS; Jeong MH; Kim W;
PLoS One; 2015; 10(12):e0144602. PubMed ID: 26658751
[TBL] [Abstract][Full Text] [Related]
37. Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort study.
Dong YH; Chang CH; Lin JW; Yang WS; Wu LC; Toh S
Diabetes Obes Metab; 2022 Aug; 24(8):1623-1637. PubMed ID: 35491533
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Pan Y; Davis PB; Kaebler DC; Blankfield RP; Xu R
Cardiovasc Diabetol; 2022 Sep; 21(1):170. PubMed ID: 36050764
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of hyperlactatemia in infected patients admitted to intensive care units: a multicenter study.
Silva CM; Baptista JP; Mergulhão P; Froes F; Gonçalves-Pereira J; Pereira JM; Dias CC; Paiva JA
Rev Bras Ter Intensiva; 2022; 34(1):154-162. PubMed ID: 35766665
[TBL] [Abstract][Full Text] [Related]
40. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.
Wang W; Wang CY; Wang SI; Wei JC
EClinicalMedicine; 2022 Nov; 53():101619. PubMed ID: 35971425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
